These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38128393)

  • 1. Modified Hu-lu-ba-wan protects diabetic glomerular podocytes via promoting PKM2-mediated mitochondrial dynamic homeostasis.
    Gong M; Guo Y; Dong H; Wu F; He Q; Gong J; Lu F
    Phytomedicine; 2024 Jan; 123():155247. PubMed ID: 38128393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction.
    Qin X; Zhao Y; Gong J; Huang W; Su H; Yuan F; Fang K; Wang D; Li J; Zou X; Xu L; Dong H; Lu F
    Theranostics; 2019; 9(6):1698-1713. PubMed ID: 31037132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine protects against diabetic kidney disease via promoting PGC-1α-regulated mitochondrial energy homeostasis.
    Qin X; Jiang M; Zhao Y; Gong J; Su H; Yuan F; Fang K; Yuan X; Yu X; Dong H; Lu F
    Br J Pharmacol; 2020 Aug; 177(16):3646-3661. PubMed ID: 31734944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
    Wu M; Yoon CY; Park J; Kim G; Nam BY; Kim S; Park JT; Han SH; Kang SW; Yoo TH
    Diabetologia; 2024 Sep; 67(9):1980-1997. PubMed ID: 38879617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirt6 ameliorates high glucose-induced podocyte cytoskeleton remodeling via the PI3K/AKT signaling pathway.
    Zhang Z; Huang H; Tao Y; Liu H; Fan Y
    Ren Fail; 2024 Dec; 46(2):2410396. PubMed ID: 39378103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplemented Gegen Qinlian Decoction Formula attenuates podocyte mitochondrial fission and renal fibrosis in diabetic kidney disease by inhibiting TNF-α-mediated necroptosis, compared with empagliflozin.
    Wang Y; Yu L; Li Y; Cha S; Shi L; Wang J; Ge F; Huang C; Huang H; Tu Y; Wan Y; Shen S
    J Ethnopharmacol; 2024 Nov; 334():118572. PubMed ID: 39025164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.
    Qi W; Keenan HA; Li Q; Ishikado A; Kannt A; Sadowski T; Yorek MA; Wu IH; Lockhart S; Coppey LJ; Pfenninger A; Liew CW; Qiang G; Burkart AM; Hastings S; Pober D; Cahill C; Niewczas MA; Israelsen WJ; Tinsley L; Stillman IE; Amenta PS; Feener EP; Vander Heiden MG; Stanton RC; King GL
    Nat Med; 2017 Jun; 23(6):753-762. PubMed ID: 28436957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling.
    Kang JS; Cho NJ; Lee SW; Lee JG; Lee JH; Yi J; Choi MS; Park S; Gil HW; Oh JC; Son SS; Park MJ; Moon JS; Lee D; Kim SY; Yang SH; Kim SS; Lee ES; Chung CH; Park J; Lee EY
    Metabolism; 2024 Oct; 159():155982. PubMed ID: 39089491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
    Tagaya M; Kume S; Yasuda-Yamahara M; Kuwagata S; Yamahara K; Takeda N; Tanaka Y; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Ishihara N; Nomura M; Araki SI; Maegawa H
    Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166368. PubMed ID: 35202791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.
    Zhang Y; Xia S; Tian X; Yuan L; Gao Y; Liu D; Qi H; Wang S; Liu Z; Li Y; Zhao Z; Liu W
    FASEB J; 2024 May; 38(10):e23668. PubMed ID: 38742811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-29b Plays a Vital Role in Podocyte Injury and Glomerular Diseases through Inducing Mitochondrial Dysfunction.
    Liu J; Xiong Y; Mo H; Niu H; Miao J; Shen W; Zhou S; Wang X; Li X; Zhang Y; Ma K; Zhou L
    Int J Biol Sci; 2024; 20(12):4654-4673. PubMed ID: 39309435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALCAT1-mediated abnormal cardiolipin remodelling promotes mitochondrial injury in podocytes in diabetic kidney disease.
    Hao Y; Fan Y; Feng J; Zhu Z; Luo Z; Hu H; Li W; Yang H; Ding G
    Cell Commun Signal; 2024 Jan; 22(1):26. PubMed ID: 38200543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway.
    Han X; Wang J; Li R; Huang M; Yue G; Guan L; Deng Y; Cai W; Xu J
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response.
    Liu Y; Zhang L; Zhang S; Liu J; Li X; Yang K; Yang D; Liu Y; Sun L; Liu F; Xiao L
    Mol Med; 2023 Apr; 29(1):57. PubMed ID: 37095454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease.
    Guo Y; Wang M; Liu Y; Pang Y; Tian L; Zhao J; Liu M; Shen C; Meng Y; Wang Y; Cai Z; Zhao W
    Chin Med; 2023 Mar; 18(1):32. PubMed ID: 36967383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects and mechanisms of total flavones of Abelmoschus manihot in improving insulin resistance and podocyte epithelial-mesenchymal transition in diabetic kidney disease based on IRS1/PI3K/Akt pathway].
    Wang Y; Cao DW; Wan YG; Mu GL; Wu W; Fang QJ; Li YJ; Cha SY; Tu Y; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2646-2656. PubMed ID: 37282926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.